title: Atrial flutter with 1 : 1 atrioventricular conduction after administration of vernakalant for atrial fibrillation.
authors.affiliation: Department of Cardiology, Stadtspital Triemli, Birmensdorferstrasse 497, 8063 Zürich, Switzerland.
authors.forename: Christine
authors.initials: C
authors.lastname: Franzini
authors.forename: Stephan Andreas
authors.initials: SA
authors.lastname: Müller-Burri
authors.forename: Dipen C
authors.initials: DC
authors.lastname: Shah
mesh_terms: D000328:Adult; D000840:Anisoles / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D001282:Atrial Flutter / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*; D005260:Female; D006801:Humans; D011759:Pyrrolidines / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000840:Anisoles; D000889:Anti-Arrhythmia Agents; D011759:Pyrrolidines; C524581:vernakalant